Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Mohammad

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
International Journal of Pharmaceutics|October 16, 2024
Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tabletsDiaa Shakleya, Alaadin Alayoubi, Dustin Brown, et al.
Journal of Pharmaceutical Sciences|June 26, 2023
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide TabletsDiaa Shakleya, Bethel Asmelash, Alaadin Alayoubi, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
International Journal of Pharmaceutics|October 16, 2024
Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tabletsDiaa Shakleya, Alaadin Alayoubi, Dustin Brown, et al.
Journal of Pharmaceutical Sciences|June 26, 2023
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide TabletsDiaa Shakleya, Bethel Asmelash, Alaadin Alayoubi, et al.
Pageof 4